Correlation Between Icosavax and Monte Rosa
Can any of the company-specific risk be diversified away by investing in both Icosavax and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Icosavax and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Icosavax and Monte Rosa Therapeutics, you can compare the effects of market volatilities on Icosavax and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Icosavax with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Icosavax and Monte Rosa.
Diversification Opportunities for Icosavax and Monte Rosa
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Icosavax and Monte is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Icosavax and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and Icosavax is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Icosavax are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of Icosavax i.e., Icosavax and Monte Rosa go up and down completely randomly.
Pair Corralation between Icosavax and Monte Rosa
If you would invest 639.00 in Monte Rosa Therapeutics on August 29, 2024 and sell it today you would earn a total of 221.00 from holding Monte Rosa Therapeutics or generate 34.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 1.56% |
| Values | Daily Returns |
Icosavax vs. Monte Rosa Therapeutics
Performance |
| Timeline |
| Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Monte Rosa Therapeutics |
Icosavax and Monte Rosa Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Icosavax and Monte Rosa
The main advantage of trading using opposite Icosavax and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Icosavax position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.| Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
| Monte Rosa vs. Valneva SE ADR | Monte Rosa vs. Bright Minds Biosciences | Monte Rosa vs. HP Inc | Monte Rosa vs. Intel |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |